FogChain Corp. (CSE: FOG.X) (OTCB: FOGCF) (FRA: MUU3) (the “Company” or “FogChain”) is pleased to announce, further to its news release dated January 13, 2021, the Company has entered into a merger agreement and plan of reorganization (the “Definitive Agreement”) with Avisa Pharma Inc. (“Avisa”) and FogChain USA Inc., a wholly-owned subsidiary of FogChain. Avisa has developed a quantitative, point–of–care diagnostic breath test known as the Avisa BreathTest (“ABT”) for rapidly detecting bacterial pneumonia and pulmonary infections in approximately 10 minutes.
Read the full article: FogChain Announces Definitive Agreement for the Acquisition of Avisa Pharma Inc. //
Source: https://www.newswire.ca/news-releases/fogchain-announces-definitive-agreement-for-the-acquisition-of-avisa-pharma-inc–807590786.html